Chou Judy - 12 Jul 2021 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: Director
Signature: / s/ Jonathan Young, attorney-in-fact
Issuer symbol: AKRO
Transactions as of: 12 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 14 Jul 2021, 16:08:21 UTC
Next filing: 03 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney